Literature DB >> 31090224

Resveratrol alleviates nuclear factor-κB-mediated neuroinflammation in vasculitic peripheral neuropathy induced by ischaemia-reperfusion via suppressing endoplasmic reticulum stress.

Po-Ting Pan1, Han-Yu Lin1,2, Ching-Wei Chuang1,2, Po-Kai Wang2, Hung-Chieh Wan1, Ming-Cheng Lee3, Ming-Chang Kao1,2.   

Abstract

Vasculitic peripheral neuropathy (VPN) arises from an inflammatory obstruction in the blood vessels supplying peripheral nerves and subsequent ischaemic insults, which exhibits the clinical features of neuropathic pain and impaired peripheral nerve function. VPN induced by ischaemia-reperfusion (IR) has been reported to involve nuclear factor-κB (NF-κB)-mediated neuroinflammation. Recent studies have suggested that endoplasmic reticulum (ER) stress has been implicated in the development of peripheral neuropathies. Resveratrol possesses a potent anti-inflammatory capacity. We hypothesized that resveratrol may exert a protective effect against VPN through modulating the interrelated ER stress and NF-κB pathways. Male Sprague-Dawley rats were allocated into five groups: sham, sham + resveratrol 40 mg/kg (R40), IR, IR + R20 and IR + R40. VPN was induced by occluding the right femoral artery for 4 hours followed by reperfusion. Our data have shown that VPN induced by IR led to hind paw mechanical allodynia, heat hyperalgaesia, and impaired motor nerve conduction velocity (MNCV). With resveratrol intervention, the behavioural parameters were improved in a dose-dependent manner and the MNCV levels were increased as well. The molecular data revealed that VPN induced by IR significantly increased the expression of NF-κB as well as the ER stress sensor proteins, protein kinase RNA-like endoplasmic reticulum kinase, inositol-requiring enzyme 1 and activating transcription factor 6 in the sciatic nerves. More importantly, resveratrol significantly attenuated the expression of NF-κB and the ER stress sensor proteins after IR. In conclusion, resveratrol alleviates VPN induced by IR. The mechanisms may involve modulating NF-κB-mediated neuroinflammation via suppressing ER stress.
© 2019 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  endoplasmic reticulum stress; neuroinflammation; neuropathic pain; polyphenol; resveratrol

Year:  2019        PMID: 31090224     DOI: 10.1111/1440-1681.13105

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

1.  Resveratrol Alleviates the Inhibitory Effect of Tunicamycin-Induced Endoplasmic Reticulum Stress on Expression of Genes Involved in Thyroid Hormone Synthesis in FRTL-5 Thyrocytes.

Authors:  Gaiping Wen; Klaus Eder; Robert Ringseis
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 2.  Polyphenols from Food and Natural Products: Neuroprotection and Safety.

Authors:  Rui F M Silva; Lea Pogačnik
Journal:  Antioxidants (Basel)       Date:  2020-01-10

Review 3.  Endoplasmic Reticulum Stress in Chemotherapy-Induced Peripheral Neuropathy: Emerging Role of Phytochemicals.

Authors:  Yugal Goel; Raghda Fouda; Kalpna Gupta
Journal:  Antioxidants (Basel)       Date:  2022-01-28

4.  In vitro study of the effect of resveratrol purified from the skin of Iraqi black grape (Vitis vinifera) on lymphocyte cultures isolated from the blood of patients with lymphoma.

Authors:  Zainab Yaseen Mohammed Hasan; Fatma Abd Alhamza Obed; Ahmed Abdulmunem Jasim; Alaa Fadhil Alwan
Journal:  J Med Life       Date:  2022-06

5.  Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation.

Authors:  Megha Jhanji; Chintada Nageswara Rao; Mathew Sajish
Journal:  Geroscience       Date:  2020-11-27       Impact factor: 7.713

6.  Resveratrol decreases high glucose‑induced apoptosis in renal tubular cells via suppressing endoplasmic reticulum stress.

Authors:  Jing Zhang; Xiong-Jun Dong; Meng-Ru Ding; Chun-Yu You; Xin Lin; Ying Wang; Miao-Jie-Yang Wu; Guo-Fei Xu; Guo-Dong Wang
Journal:  Mol Med Rep       Date:  2020-09-15       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.